These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5973379)

  • 41. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
    Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
    Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. USOL-D bac (type 3 poliovirus) vaccine studies.
    Bull World Health Organ; 1969; 40(2):295-300. PubMed ID: 5306547
    [No Abstract]   [Full Text] [Related]  

  • 48. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.
    Estívariz CF; Watkins MA; Handoko D; Rusipah R; Deshpande J; Rana BJ; Irawan E; Widhiastuti D; Pallansch MA; Thapa A; Imari S
    J Infect Dis; 2008 Feb; 197(3):347-54. PubMed ID: 18199031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The behavior of homologous and heterologous complement-fixing antibodies against poliomyelitis after oral vaccination with Sabin's live vaccine].
    Altevogt R
    Z Immunitatsforsch Allerg Klin Immunol; 1965 Sep; 129(3):296-301. PubMed ID: 4223286
    [No Abstract]   [Full Text] [Related]  

  • 51. Persistence of poliovirus neutralizing antibodies four years after immunization with live attenuated vaccine.
    Cesario TC; Jones V; Poland JD; Chin TD
    Am J Epidemiol; 1969 Aug; 90(2):157-61. PubMed ID: 5804362
    [No Abstract]   [Full Text] [Related]  

  • 52. [Behavior of the glutamic-oxalacetic and pyruvic transaminases in the course of Sabin's antipoliomyelitic vaccination].
    Monari E; Mei V
    Clin Pediatr (Bologna); 1966 Apr; 48(4):153-61. PubMed ID: 5961326
    [No Abstract]   [Full Text] [Related]  

  • 53. [STUDIES ON THE DETECTION OF NEUTRALIZING AND COMPLEMENT BINDING ANTIBODIES FOLLOWING ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Klin Wochenschr; 1965 May; 43():562-9. PubMed ID: 14304399
    [No Abstract]   [Full Text] [Related]  

  • 54. [Poliomyelitis antibodies in Swiss and Italian temporary workers].
    Just M; Gsell O
    Schweiz Med Wochenschr; 1967 Jul; 97(27):885-6. PubMed ID: 5592585
    [No Abstract]   [Full Text] [Related]  

  • 55. Oral poliovirus vaccine.
    BURNEY LE
    Public Health Rep (1896); 1960 Oct; 75(10):869-71. PubMed ID: 13689178
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunity of school children two years after oral poliomyelitis vaccination.
    Lepow ML; Nankervis GA; Robbins FC
    JAMA; 1967 Oct; 202(1):121-5. PubMed ID: 6071999
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral poliomyelitis vaccine program in Cincinnati.
    PORTER ER; WEHR RE
    Public Health Rep (1896); 1961 May; 76(5):369-74. PubMed ID: 13737269
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral poliomyelitis vaccine.
    SHANHOLTZ MI
    Va Med Mon (1918); 1961 Nov; 88():666-8. PubMed ID: 13911218
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral poliomyelitis vaccine, Lederle -- thirteen years of laboratory and field investigation. An interim review.
    Cabasso BJ; Jungherr EL; Moyer AW; Roca-Garcia M; Cox HR
    N Engl J Med; 1960 Dec; 263():1321-30. PubMed ID: 13689638
    [No Abstract]   [Full Text] [Related]  

  • 60. Orally-administered poliomyelitis vaccine proves effective.
    NORTHINGTON JM
    Clin Med (Northfield); 1962 Jan; 69():19-22. PubMed ID: 15445836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.